Preethi Krishnan

3.8k total citations
58 papers, 2.1k citations indexed

About

Preethi Krishnan is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Preethi Krishnan has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 32 papers in Infectious Diseases and 31 papers in Epidemiology. Recurrent topics in Preethi Krishnan's work include Hepatitis C virus research (35 papers), HIV/AIDS drug development and treatment (29 papers) and Hepatitis B Virus Studies (19 papers). Preethi Krishnan is often cited by papers focused on Hepatitis C virus research (35 papers), HIV/AIDS drug development and treatment (29 papers) and Hepatitis B Virus Studies (19 papers). Preethi Krishnan collaborates with scholars based in United States, Japan and United Kingdom. Preethi Krishnan's co-authors include Kenneth F. Bastow, Edward Tam, Thomas Reisch, Jill Beyer, Rakesh Tripathi, Christine A. Collins, Michelle Irvin, Gretja Schnell, Akhteruzzaman Molla and Yung‐Chi Cheng and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Preethi Krishnan

57 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Preethi Krishnan United States	26	1.5k	1.2k	734	407	121	58	2.1k
Makonen Belema United States	13	749 0.5×	558 0.5×	322 0.4×	280 0.7×	292 2.4×	18	1.2k
Van N. Nguyen United States	12	639 0.4×	498 0.4×	260 0.4×	219 0.5×	303 2.5×	14	1.1k
Michael H. Serrano‐Wu United States	18	795 0.5×	633 0.5×	350 0.5×	342 0.8×	307 2.5×	31	1.4k
Pierre Raboisson Belgium	24	636 0.4×	534 0.4×	497 0.7×	634 1.6×	555 4.6×	60	1.8k
Mark W. Stahlhut United States	21	472 0.3×	390 0.3×	656 0.9×	600 1.5×	264 2.2×	45	1.7k
Tsuyoshi Adachi Japan	12	694 0.5×	406 0.3×	305 0.4×	370 0.9×	177 1.5×	20	1.2k
Ernest Asante‐Appiah United States	21	241 0.2×	293 0.2×	655 0.9×	958 2.4×	151 1.2×	47	1.6k
Marc Bifano United States	22	823 0.6×	859 0.7×	378 0.5×	164 0.4×	76 0.6×	42	1.3k
Kyun‐Hwan Kim South Korea	28	677 0.5×	929 0.8×	175 0.2×	677 1.7×	115 1.0×	83	1.8k
Rozenn Brillet France	15	503 0.3×	451 0.4×	179 0.2×	234 0.6×	123 1.0×	25	986

Countries citing papers authored by Preethi Krishnan

Since Specialization

Citations

This map shows the geographic impact of Preethi Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preethi Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preethi Krishnan more than expected).

Fields of papers citing papers by Preethi Krishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preethi Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preethi Krishnan. The network helps show where Preethi Krishnan may publish in the future.

Co-authorship network of co-authors of Preethi Krishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Preethi Krishnan. A scholar is included among the top collaborators of Preethi Krishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preethi Krishnan. Preethi Krishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ideozu, Justin E., Mengzhen Liu, Bridget Riley‐Gillis, et al.. (2024). Diversity of CFTR variants across ancestries characterized using 454,727 UK biobank whole exome sequences. Genome Medicine. 16(1). 43–43. 10 indexed citations

Krishnan, Preethi, Carly A. Bobak, & Jane E. Hill. (2024). Sex-specific blood-derived RNA biomarkers for childhood tuberculosis. Scientific Reports. 14(1). 16859–16859. 2 indexed citations

Krishnan, Preethi, Philip Yang, Sivasubramanium V. Bhavani, et al.. (2023). HIRA: Heart Rate Interval based Rapid Alert score to characterize autonomic dysfunction among patients with sepsis-related acute respiratory failure (ARF). Physiological Measurement. 44(10). 105006–105006.

Smith, Andrew, Glen E. P. Ropella, Mitchell R. McGill, et al.. (2020). Contrasting model mechanisms of alanine aminotransferase (ALT) release from damaged and necrotic hepatocytes as an example of general biomarker mechanisms. PLoS Computational Biology. 16(6). e1007622–e1007622. 19 indexed citations

Randolph, John T., Tongmei Li, A. Chris Krueger, et al.. (2020). Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(7). 126986–126986. 3 indexed citations

Poordad, Fred, Shahriar Sedghi, Paul J. Pockros, et al.. (2019). Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis. Journal of Viral Hepatitis. 26(8). 1027–1030. 1 indexed citations

Schnell, Gretja, Preethi Krishnan, Rakesh Tripathi, et al.. (2018). Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir. PLoS ONE. 13(10). e0205186–e0205186. 10 indexed citations

Poordad, Fred, Stanislas Pol, Armen Asatryan, et al.. (2017). Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure. Hepatology. 67(4). 1253–1260. 105 indexed citations

Kumada, Hiromitsu, Tsunamasa Watanabe, Fumitaka Suzuki, et al.. (2017). Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection. Journal of Gastroenterology. 53(4). 566–575. 75 indexed citations

10.

Forns, Xavier, Samuel S. Lee, Joaquin Valdes, et al.. (2017). Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. The Lancet Infectious Diseases. 17(10). 1062–1068. 234 indexed citations

11.

Randolph, John T., Charles A. Flentge, Todd W. Rockway, et al.. (2016). Discovery of fluorobenzimidazole HCV NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(22). 5462–5467. 4 indexed citations

12.

Peters‐Libeu, Clare, Jason Miller, Earl Rutenber, et al.. (2012). Disease-Associated Polyglutamine Stretches in Monomeric Huntingtin Adopt a Compact Structure. Journal of Molecular Biology. 421(4-5). 587–600. 46 indexed citations

13.

Ng, Teresa I., Hongmei Mo, Edward Tam, et al.. (2007). Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology. 45(6). 1413–1421. 105 indexed citations

14.

Middleton, Tim, Yupeng He, Edward Tam, et al.. (2007). A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations. Journal of Virological Methods. 145(2). 137–145. 25 indexed citations

15.

Tripathi, Rakesh, Preethi Krishnan, Yupeng He, et al.. (2006). Replication efficiency of chimeric replicon containing NS5A–5B genes derived from HCV-infected patient sera. Antiviral Research. 73(1). 40–49. 27 indexed citations

16.

Feng, Joy Y., William B. Parker, Megan L. Krajewski, et al.. (2004). Anabolism of amdoxovir: phosphorylation of dioxolane guanosine and its 5′-phosphates by mammalian phosphotransferases. Biochemical Pharmacology. 68(9). 1879–1888. 15 indexed citations

17.

Liou, Jieh-Yuan, Preethi Krishnan, Cheng‐Chih Hsieh, Ginger E. Dutschman, & Yung‐Chi Cheng. (2003). Assessment of the Effect of Phosphorylated Metabolites of Anti-Human Immunodeficiency Virus and Anti-Hepatitis B Virus Pyrimidine Analogs on the Behavior of Human Deoxycytidylate Deaminase. Molecular Pharmacology. 63(1). 105–110. 11 indexed citations

18.

Krishnan, Preethi, Jieh-Yuan Liou, & Yung‐Chi Cheng. (2002). Phosphorylation of Pyrimidine l-Deoxynucleoside Analog Diphosphates. Journal of Biological Chemistry. 277(35). 31593–31600. 27 indexed citations

19.

Krishnan, Preethi & Kenneth F. Bastow. (2001). Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives α-lapachone and β-lapachone. Cancer Chemotherapy and Pharmacology. 47(3). 187–198. 47 indexed citations

20.

Tachibana, Yoko, Xiaokang Zhu, Preethi Krishnan, Kuo‐Hsiung Lee, & Kenneth F. Bastow. (2000). Characterization of human lung cancer cells resistant to 4′-O-demethyl-4β-(2′′-nitro-4′′-fluoroanilino)-4-desoxypodophyllotoxin, a unique compound in the epipodophyllotoxin antitumor class. Anti-Cancer Drugs. 11(1). 19–28. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact